Ownership

John Vavricka - Chief Commercial Officer at Atea Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Commercial Officer
Stock Symbol: AVIR on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

John Vavricka - trading volume in the past year for Atea Pharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-11.8K	100%	$3.84	-$45.4K
Net	-11.8K	-100%		-$45.4K

Holdings reported by John Vavricka for Atea Pharmaceuticals, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	82.5K	$317K	$3.84	Jan 31, 2024	Held by John Vavricka as the Trustee of the John F. Vavricka Deed of Trust
Restricted Stock Units	66.7K	$256K	$3.84	Jan 31, 2024	Direct	Common Stock
Common Stock	21.5K	$82.7K	$3.84	Feb 1, 2024	Direct
Stock Option (Right to Buy)	133K			Jan 31, 2024	Direct	Common Stock

Transactions reported by John Vavricka for Atea Pharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.